Latest Breaking News On - Skipping therapy - Page 1 : comparemela.com

This year’s top content in the Duchenne muscular dystrophy (DMD) space focused on a novel gene therapy approval, the high cost of care for this genetic disorder, and steps forward in other treatments.

United statesSarah boyceHealth care resource utilizationSanthera pharmaceuticalsAmerican journalTreat duchenne muscularBiosciences gainsDrug designationPatients withAvidity biosciencesPatient death following high dose gene therapySkipping therapyHigh care costsHealth care resourceOrphan drug designationExon skipping therapy